313 related articles for article (PubMed ID: 23251626)
21. HIV-1 Tat and opioids act independently to limit antiretroviral brain concentrations and reduce blood-brain barrier integrity.
Leibrand CR; Paris JJ; Jones AM; Masuda QN; Halquist MS; Kim WK; Knapp PE; Kashuba ADM; Hauser KF; McRae M
J Neurovirol; 2019 Aug; 25(4):560-577. PubMed ID: 31102185
[TBL] [Abstract][Full Text] [Related]
22. HIV-1 Tat triggers nuclear localization of ZO-1 via Rho signaling and cAMP response element-binding protein activation.
Zhong Y; Zhang B; Eum SY; Toborek M
J Neurosci; 2012 Jan; 32(1):143-50. PubMed ID: 22219277
[TBL] [Abstract][Full Text] [Related]
23. HIV-TAT protein upregulates expression of multidrug resistance protein 1 in the blood-brain barrier.
Hayashi K; Pu H; Andras IE; Eum SY; Yamauchi A; Hennig B; Toborek M
J Cereb Blood Flow Metab; 2006 Aug; 26(8):1052-65. PubMed ID: 16395283
[TBL] [Abstract][Full Text] [Related]
24. Characterization of platelet-monocyte complexes in HIV-1-infected individuals: possible role in HIV-associated neuroinflammation.
Singh MV; Davidson DC; Jackson JW; Singh VB; Silva J; Ramirez SH; Maggirwar SB
J Immunol; 2014 May; 192(10):4674-84. PubMed ID: 24729609
[TBL] [Abstract][Full Text] [Related]
25. HIV-1 viral proteins gp120 and Tat induce oxidative stress in brain endothelial cells.
Price TO; Ercal N; Nakaoke R; Banks WA
Brain Res; 2005 May; 1045(1-2):57-63. PubMed ID: 15910762
[TBL] [Abstract][Full Text] [Related]
26. Permeability of the blood-brain barrier to HIV-1 Tat.
Banks WA; Robinson SM; Nath A
Exp Neurol; 2005 May; 193(1):218-27. PubMed ID: 15817280
[TBL] [Abstract][Full Text] [Related]
27. Viral Infection of the Central Nervous System and Neuroinflammation Precede Blood-Brain Barrier Disruption during Japanese Encephalitis Virus Infection.
Li F; Wang Y; Yu L; Cao S; Wang K; Yuan J; Wang C; Wang K; Cui M; Fu ZF
J Virol; 2015 May; 89(10):5602-14. PubMed ID: 25762733
[TBL] [Abstract][Full Text] [Related]
28. HIV-1 Tat protein alters tight junction protein expression and distribution in cultured brain endothelial cells.
András IE; Pu H; Deli MA; Nath A; Hennig B; Toborek M
J Neurosci Res; 2003 Oct; 74(2):255-65. PubMed ID: 14515355
[TBL] [Abstract][Full Text] [Related]
29. Overview on the Tricks of HIV Tat to Hit the Blood Brain Barrier.
Singh SK
Curr HIV Res; 2016; 14(5):382-388. PubMed ID: 27719664
[TBL] [Abstract][Full Text] [Related]
30. A helping HAND: therapeutic potential of MAGL inhibition against HIV-1-associated neuroinflammation.
League AF; Yadav-Samudrala BJ; Kolagani R; Cline CA; Jacobs IR; Manke J; Niphakis MJ; Cravatt BF; Lichtman AH; Ignatowska-Jankowska BM; Fitting S
Front Immunol; 2024; 15():1374301. PubMed ID: 38835765
[TBL] [Abstract][Full Text] [Related]
31. Brain-derived human immunodeficiency virus-1 Tat exerts differential effects on LTR transactivation and neuroimmune activation.
Boven LA; Noorbakhsh F; Bouma G; van der Zee R; Vargas DL; Pardo C; McArthur JC; Nottet HS; Power C
J Neurovirol; 2007 Apr; 13(2):173-84. PubMed ID: 17505986
[TBL] [Abstract][Full Text] [Related]
32. The HIV-1 Matrix Protein p17 Does Cross the Blood-Brain Barrier.
Caccuri F; Neves V; Gano L; Correia JDG; Oliveira MC; Mazzuca P; Caruso A; Castanho M
J Virol; 2022 Jan; 96(1):e0120021. PubMed ID: 34668776
[TBL] [Abstract][Full Text] [Related]
33. HIV-1 Tat disrupts blood-brain barrier integrity and increases phagocytic perivascular macrophages and microglia in the dorsal striatum of transgenic mice.
Leibrand CR; Paris JJ; Ghandour MS; Knapp PE; Kim WK; Hauser KF; McRae M
Neurosci Lett; 2017 Feb; 640():136-143. PubMed ID: 28057474
[TBL] [Abstract][Full Text] [Related]
34. HIV proteins (gp120 and Tat) and methamphetamine in oxidative stress-induced damage in the brain: potential role of the thiol antioxidant N-acetylcysteine amide.
Banerjee A; Zhang X; Manda KR; Banks WA; Ercal N
Free Radic Biol Med; 2010 May; 48(10):1388-98. PubMed ID: 20188164
[TBL] [Abstract][Full Text] [Related]
35. Human immunodeficiency virus-1 Tat exerts its neurotoxic effects by downregulating Sonic hedgehog signaling.
Khan IA; Worrad AH; Singh MV; Maggirwar SB; Singh VB
J Neurovirol; 2022 Apr; 28(2):305-311. PubMed ID: 35181862
[TBL] [Abstract][Full Text] [Related]
36. The CD40/CD40L system regulates rat cerebral microvasculature after focal ischemia/reperfusion via the mTOR/S6K signaling pathway.
Jiang RH; Xu XQ; Wu CJ; Lu SS; Zu QQ; Zhao LB; Liu S; Shi HB
Neurol Res; 2018 Sep; 40(9):717-723. PubMed ID: 29843579
[TBL] [Abstract][Full Text] [Related]
37. Targeting Cannabinoid Receptor 2 on Peripheral Leukocytes to Attenuate Inflammatory Mechanisms Implicated in HIV-Associated Neurocognitive Disorder.
Rizzo MD; Henriquez JE; Blevins LK; Bach A; Crawford RB; Kaminski NE
J Neuroimmune Pharmacol; 2020 Dec; 15(4):780-793. PubMed ID: 32409991
[TBL] [Abstract][Full Text] [Related]
38. Chronic morphine and HIV-1 Tat promote differential central nervous system trafficking of CD3+ and Ly6C+ immune cells in a murine Streptococcus pneumoniae infection model.
Dutta R; Roy S
J Neuroinflammation; 2015 Jun; 12():120. PubMed ID: 26087960
[TBL] [Abstract][Full Text] [Related]
39. HIV and viral protein effects on the blood brain barrier.
McRae M
Tissue Barriers; 2016; 4(1):e1143543. PubMed ID: 27141423
[TBL] [Abstract][Full Text] [Related]
40. Leukocyte transmigration across the blood-brain barrier: perspectives on neuroAIDS.
Roberts TK; Buckner CM; Berman JW
Front Biosci (Landmark Ed); 2010 Jan; 15(2):478-536. PubMed ID: 20036831
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
